机译:高亲和力T细胞受体样抗体的合理开发
Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford 0X3 9DS, United Kingdom;
Department of Oncology, University Hospital Zurich, CH-8091 Zurich, Switzerland;
Centre for Molecular Medicine and Klinik I fur Innere Medizin, Labor Tumorgenetik, Universitat zu Kbln, 50924 Cologne, Germany;
Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford 0X3 9DS, United Kingdom;
Medical Department I, Saarland University Medical School, D-66421 Homburg, Germany;
Department of Oncology, University Hospital Zurich, CH-8091 Zurich, Switzerland;
Department of Oncology, University Hospital Zurich, CH-8091 Zurich, Switzerland;
Department of Oncology, University Hospital Zurich, CH-8091 Zurich, Switzerland;
Department of Oncology, University Hospital Zurich, CH-8091 Zurich, Switzerland;
Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford 0X3 9DS, United Kingdom;
Department of Oncology, University Hospital Zurich, CH-8091 Zurich, Switzerland;
Centre for Molecular Medicine and Klinik I fur Innere Medizin, Labor Tumorgenetik, Universitat zu Kbln, 50924 Cologne, Germany;
Centre for Molecular Medicine and Klinik I fur Innere Medizin, Labor Tumorgenetik, Universitat zu Kbln, 50924 Cologne, Germany;
Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford 0X3 9DS, United Kingdom;
Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom;
Department of Oncology, University Hospital Zurich, CH-8091 Zurich, Switzerland;
机译:对次要组织相容性抗原HA-1H特异的T细胞受体样抗体和CAR-T细胞的构建和分子表征
机译:T细胞受体样抗体:靶向细胞内蛋白质组治疗潜力和临床应用
机译:使用T细胞受体样抗体靶向将干扰素-α靶向感染乙肝病毒的细胞
机译:开发一种完全人体T细胞接合双特异性抗体治疗多发性骨髓瘤
机译:人CD19 / CD3双特异性T细胞衔接子(BiTERTM)抗体blinatumomab与杂种鼠替代CD19 / CD3 BiTE抗体hyS103的比较药理学。
机译:高亲和力T细胞受体样抗体的合理开发
机译:高亲和力T细胞受体样抗体的合理开发(第106卷,第5784页,2009)